RSO-021, a first-in-class covalent inhibitor of mitochondrial PRX3: From bench to bedsideDean A. Fennell,Sean Dulloo,Peter Szlosarek,Fiona Thistlethwaite,Simon Lord, Najib M. Rahman,Brian Cunniff,Joanna Dzialo,Charlotte Poile, Rakesh Panchal, Jarrett Duncan, Pip Graham, Alice Bexon,George N. Naumov,James SpicerMOLECULAR CANCER THERAPEUTICS(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要